1.3 Lakh Fully Vaccinated In Bhubaneswar; How Many Vaccines Are Left In Odishaby OB Bureau 4 years ago 0 Bhubaneswar: Odisha has inoculated over 60 lakh people with at least 1 dose of the COVID-19 vaccine. Of these, more ...
Now, Covaxin Price Lowered To Rs 400 Per Dose For Statesby OB Bureau 4 years ago 0 Hyderabad: Taking a cue from Serum Institute of India (SII), Bharat Biotech on Thursday announced reduction in the price of ...
Covaxin Costlier Than Covishield: Rs 1200 Per Dose For Private Hospitals, Rs 600 For Statesby OB Bureau 4 years ago 0 Hyderabad: Covaxin will be more expensive than Covishield in private hospitals from May 1. The Hyderabad-based Bharat Biotech, which is ...
Govt To Procure COVID Vaccines At Rs 150 Per Doseby OB Bureau 4 years ago 0 New Delhi: Following the confusion over the price of the COVID-19 vaccines — Covishield and Covaxin — the central government ...
Good News: Covaxin Shows 78% Efficacy In Phase 3 Interim Analysisby OB Bureau 4 years ago 0 Hyderabad: For those who are still a tad hesitant in taking the Covaxin jab, there’s reassuring news. The phase 3 ...
320 Doses Of Covaxin Stolen From This Govt Hospitalby OB Bureau 4 years ago 0 Jaipur: Over 300 doses of Bharat Biotech's Covaxin have been stolen from a hospital in Jaipur. A total of 320 ...
Bharat Biotech’s Covaxin Not Upto Manufacturing Standards, Says Brazilby OB Bureau 4 years ago 0 Rio de Janeiro: Brazil’s health regulator Anvisa has said that Covaxin did not meet its manufacturing standards. The Brazilian government ...
No Clotting, Unusual Bleeding After Indian Vaccines, Says Govt Panelby OB Bureau 4 years ago 0 New Delhi: A committee set up by the government on Monday, allayed the fear of people that Covishield and Covaxin ...
Expert Panel Clears Covaxin After Promising Phase 3 Trial Databy OB Bureau 4 years ago 0 New Delhi: Bharat Biotech’s COVID-19 vaccine Covaxin can be granted Emergency Use Approval, Drug regulator’s Subject Expert Committee (SEC) recommended ...
Covaxin Safe With No Serious Side Effects, Reports Lancetby OB Bureau 4 years ago 0 New Delhi: Covaxin, the indigenous coronavirus vaccine that was authorized for use in January before full clinical trial data, has ...